RE:Congrats ... a potential Mickey Mouse deal"It's takes a special kind of CEO not to sign an initial commerical deal for PGX to show proof of concept."
Ciao is the submissive beta male who doesn't believe he can be a success any other way than to sell out in a Mickey Mouse deal based on a 10L pilot scale plant and sit back and collect a tiny royalty.
It takes an alpha male to create a profitable base business to finance and keep 100% control of PGX to the commercial goal line. Informed by talks with industry Gilles also turned PGX-oat beta glucan into PGX-YBG. Gilles created a masterpiece. 100% ownership. Commercial scale validation. Masterpiece.
- PGX-YBG blows PGX-oat beta glucan away in terms of bioavailability.
- PGX-YBG could profoundly alter the treatment landscape for fibrosis according to Dr. Martin Kolb.
- PGX-YBG is 5X more binding capacity to dectin-1 and is the potential gold standard immune booster.
Based on results Gilles has attracted Ronnie Miller who is arguably the most important biotech executive in Canada in the last 20 years. The Canadian government has provided increased funding over time. The merger with AEZS arguably targets CZO from $1.25 to $2.20 per share based on HC Wainwrights target prices for AEZS in the last year and that it is a merger of equals.